Cameron J.
Turtle
M.B.B.S.
Ph.D.
Photo: Fred Hutch
Education, Training, Board Certifications
- M.B.B.S., The University of Sydney, Australia
- Ph.D., The University of Queensland, Australia
- Residency, University of Sydney, Australia
- F.R.A.C.P., Fellow of the Royal Australasian College of Physicians
- F.R.C.P.A., Fellow of the Royal College of Pathologists of Australasia
Clinical Expertise
- T cell immunotherapy for hematologic malignancies
- Hematopoietic stem cell transplantation
- Hematologic malignancies
Affiliations
Publications
Research and/or clinical interests
Dr. Cameron Turtle studies how immune T cells can be engineered to fight hematologic malignancies, such as non-Hodgkin lymphoma, acute lymphoblastic leukemia, chronic lymphocytic leukemia and acute myeloid leukemia. He serves as an attending physician on the Hematopoietic Cell Transplant Service and the Immunotherapy Service at Seattle Cancer Care Alliance and the UW Medical Center. His laboratory in the Clinical Research Division at Fred Hutch is focused on understanding the characteristics of distinct subsets of human CD8+ T cells, their potential utility for tumor immunotherapy, and their role in immune reconstitution after blood stem cell transplantation.
Dr. Turtle’s lab has extensive expertise in conducting investigator-initiated clinical trials of T-cell immunotherapies for patients with B-cell malignancies. The lab conducts detailed studies of the reasons for success and failure of T cell therapies in treated patients, enabling a rational approach to improving treatment of patients with cancer.